Ignite Creation Date:
2024-05-06 @ 3:48 AM
Last Modification Date:
2024-10-26 @ 11:38 AM
Study NCT ID:
NCT02370888
Status:
TERMINATED
Last Update Posted:
2020-01-27
First Post:
2015-02-10
Brief Title:
Lenalidomide After Allo-Hematopoietic Cell Transplant HCT in Acute Myelogenous Leukemia AML and Myelodysplastic Syndromes MDS Subjects With Minimal Residual Disease
Sponsor:
University of Florida
Organization:
University of Florida
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-16
Start Date Type:
ACTUAL
Primary Completion Date:
2019-05-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-05-31
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-10
First Submit QC Date:
February 24 2015
Study First Post Date:
2015-02-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-01-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-01-13
Last Update Post Date:
2020-01-27
Last Update Post Date Type:
ACTUAL